baber/WOPTO huggingface dataset:
Patent DE-69115703-T2 (DE)
Inventor: EKHOLM OLOF
IPC: F42B1/02
Filed: 1991-09-17
Granted: 1996-05-09
Abstract: The present invention relates to a projectile-forming explosive charge (1) of the type which includes a forward concave insert (2) disposed in the envisaged effect direction of the charge and being reformed on detonation of the charge into a cohesive projectile (4). According to the invention, this projectile (4) is given advantageous ballistic configuration with the aid of a specifically designed annular portion (3) which is also utilized for retaining the insert (2) in that sleeve (8) which surrounds the explosive charge (9) on other sides. <IMAGE>
Patent DE-69122957-T2 (DE)
Inventor: GRAILLAT ALAIN PAUL VICTOR
IPC: E04H15/48
Filed: 1991-02-04
Granted: 1997-05-28
Abstract: PCT No. PCT/FR91/00076 Sec. 371 Date Aug. 3, 1992 Sec. 102(e) Date Aug. 3, 1992 PCT Filed Feb. 4, 1991 PCT Pub. No. WO91/11577 PCT Pub. Date Aug. 8, 1991.A collapsible accommodation structure (1) comprising a base (2), at least two opposite side walls (3, 4) connected to said base and inwardly foldable one over the other, and a roof (7) which is connected to said opposite side walls (3, 4) so that it can be folded with the walls while being turned over so that in the collapsed position, the roof (7) lies between said walls with its top side facing the outside of one of the side walls and its underside facing the inside of the other side wall.
Patent DE-69128926-T2 (DE)
Inventor: PRAKASH NELLIKUNJA J
IPC: A61K33/243
Filed: 1991-12-12
Granted: 1998-06-04
Abstract: The present invention concerns the use of N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine in conjunction with a cytotoxic agent selected from the group consisting of an antineoplastic vinca alkaloid, an antineoplastic antibiotic, an antineoplastic antimetabolite and an antineoplastic platinum coordination complex for the preparation of a pharmaceutical composition useful in treating a patient suffering from a neoplastic disease state.
Patent DE-69200837-T2 (DE)
Inventor: GRANETO MATTHEW
IPC: C07D231/14
Filed: 1992-01-21
Granted: 1995-06-14
Abstract: Novel 3-difluoromethyl-1-methyl-N-(substituted-indane-4-yl)pyrazole-4-carbox amides useful as fungicides, particularly effective in alleviating infections in diseased plants.
Patent DE-69206486-T2 (DE)
Inventor: LAWSON ROBERT JOHN
IPC: C07C215/50
Filed: 1992-04-06
Granted: 1996-05-02
Abstract: A composition comprising at least one compound which is a 2,6-bis hydroxyalkylamino methyl phenol. The composition is typically water-based and certain of the compounds are novel. The composition or the compound may be deposited onto a metal surface. The coated metal surface can have corrosion inhibiting and/or adhesion promoting characteristics.
Patent DE-69211692-T2 (DE)
Inventor: DICKIE ROBERT
IPC: A61C5/12
Filed: 1992-03-09
Granted: 1996-12-12
Abstract: A dental matrix retainer package includes a plastic matrix retainer clamp which permits a matrix band to be unlocked from its tightened position over a tooth without releasing the matrix band from the clamp entirely, permits a matrix band to be swiveled to accommodate different mouth quadrants with removal for reorientation, permits rapid retraction of a matrix band from a tooth, and permits careful tightening of a matrix band over a tooth in order to avoid the possibility of overtightening. The package is designed so that it must be entirely disposed of after use on a patient, thereby providing maximum assurance against cross contamination.
Patent DE-69214510-T2 (DE)
Inventor: ENGSTROEM FOLKE
IPC: F23J15/02
Filed: 1992-05-07
Granted: 1997-03-27
Abstract: An apparatus for cleaning high temperature, high pressure gases includes a pressure vessel (10), and a filtration unit (28) within the pressure vessel (10). The filtration unit (28) is adapted to communicate with a fluidized bed reactor gas outlet (26), and includes at least one dirty gas chamber housing a plurality of porous, ceramic filter tubes (36), and at least one clean gas chamber (40) for receiving clean gas from the ceramic filter tubes. The dirty gas chamber includes a particle outlet (34) for removing particles separated from the gas by the filter tubes (36). The porous ceramic filter tubes (36) are horizontally oriented within the filtration unit or housing (28) and mounted within water cooled walls (30) of the housing. The fluidized bed reactor (14) and associated cyclone separator (16) may be located within the pressure vessel (10) with the filtration unit (28), or located outside the pressure vessel (10) and in communication with the filtration unit (28) inside the pressure vessel (10). <IMAGE>
Patent DE-69218540-T2 (DE)
Inventor: JONES MICHAEL EDWARD
IPC: B67C3/26
Filed: 1992-09-15
Granted: 1997-11-13
Abstract: A method of and apparatus for packaging a beverage in a container 1 having a primary chamber and a relatively smaller secondary chamber which communicates with the primary chamber by way of a restricted orifice has the exterior of the container maintained at atmospheric pressure. The container such as a can 1 to be charged with beer is engaged within a filling head block 24 through nozzles 35 from which beer 9 is to flow into the can 1 from a bowl 8. Prior to filling the can 1 is pressurised through the head 24 with nitrogen gas to greater than atmospheric pressure and subsequently evacuated to atmospheric pressure by control of valves 32, 33. Such pressurisation and evacuation may be repeated sequentially to dilute the atmospheric oxygen content within the primary and secondary chambers of the can 1 where the oxygen has negligible effect on the beer which is to be sold in the can. A gas exchange conduit 40 extends between the bowl headspace 12 and the can 1. Conduit 40 has a port 41 of a gas control valve 55 which port 41 is closable by movement of lever 60. A beer flow valve 37/46 controls flow of beer 9 from the bowl through nozzles 35. During pressurisation of the can 1 with nitrogen gas the lever 60 is adjusted to maintain closed the port 41 of the gas flow valve and the beer flow valve 37/46 to ensure that high pressure gas in the can 1 cannot flow by way of the gas exchange conduit 40 into the bowl headspace 12 and again flow through the nozzles 35 into the beer 9 in the bowl 8. <IMAGE>
Patent DE-69219913-T2 (DE)
Inventor: COAN MICHAEL H
IPC: G01N33/566
Filed: 1992-01-08
Granted: 1997-09-11
Abstract: A method of controlling the amount of a biologically active substance binding to a cell surface having both receptors to the substance and receptors for the Fc domain of an antibody that can complex with the substance or other antibodies that can complex with the substance. By exploiting the generally more numerous Fc receptor sites, substance binding can be increased and/or controlled. Method contemplates controlling amounts of substances such as cytokines, hormones, and growth factors that are associated with cells such as monocytes, macrophages, granulocytes, B cells, T cells, and platelets. Method is illustrated using conjugated antibodies to tissue necrosis factor (TNF) to increase the binding of TNF to monocytes.
Patent DE-69223262-T2 (DE)
Inventor: SUZUKI KENJI
IPC: C07D235/30
Filed: 1992-06-22
Granted: 1998-04-16
Abstract: A novel benzimidazole derivative represented by formula (I) or a pharmacologically acceptable salt thereof, a process for the production thereof, an antiemetic containing the same as the active ingredient, and an intermediate for the production of the antiemetic. The derivative has a persistent 5-HT3 antagonism and the effects of preventing and curing vomit induced by cisplatin and is lowly toxic, thus being useful as an antiemetic for vomit accompanying the chemotherapy of cancer with the use of cisplatin or the like. <CHEM>
Patent DE-69223977-T2 (DE)
Inventor: OPPONG DAVID
IPC: C10N30/16
Filed: 1992-09-24
Granted: 1998-07-09
Abstract: Synergistic combinations of 2-(Thiocyanomethylthio)-benzothiazole and a mixture of 4,4-dimethyloxazolidine and 3,4,4-trimethyloxazolidine for use in controlling the growth of at least one microorganism, such as fungi and bacteria, in aqueous fluids, such as metalworking fluids.
Patent DE-69223989-T2 (DE)
Inventor: O'NEILL BRIAN
IPC: C07D417/02
Filed: 1992-09-18
Granted: 1998-07-09
Abstract: PCT No. PCT/US92/07730 Sec. 371 Date Jul. 20, 1994 Sec. 102(e) Date Jul. 20, 1994 PCT Filed Sep. 18, 1992 PCT Pub. No. WO93/10073 PCT Pub. Date May 27, 1993.The present invention relates to novel acyclic ethylenediamine derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula    <IMAGE>  I  wherein R1, R2, R3, R4, R5 and R6 are defined as in the specification. It also relates to novel intermediates used in the synthesis of such derivatives. Compounds of the formula I and their pharmaceutically acceptable salts are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
Patent DE-69224145-T2 (DE)
Inventor: HANADA SEIGO
IPC: A61Q7/00
Filed: 1992-09-09
Granted: 1998-08-27
Abstract: A preparation for promoting hair growth is disclosed, which contains as an effective ingredient or ingredients one or more compounds selected from the group consisting of purine compounds, pyridylurea compounds, diphenylurea compounds, pyrimidine compounds, imidazole compounds, benzoylaminourea compounds and 4-substituted aminopyrroloÄ2,3-dÜpyrimidine compounds. This preparation exhibits an excellent effect of promoting hair growth or curing alopecia such as male alopecia or alopecia areata. Of the effective compounds, purine compounds and pyridyl compounds exhibit particularly remarkable effects.
Patent DE-69227693-T2 (DE)
Inventor: TODARO GEORGE
IPC: C07K14/00
Filed: 1992-08-24
Granted: 1999-07-22
Abstract: Hybrid cytokines containing four helical regions, each of which is derived from a corresponding alpha-helical region in leukemia inhibitory factor (LIF), granulocyte colony stimulating factor (G-CSF), interleukin-6 (IL-6) or oncostatin-M (OSM) are disclosed. These hybrid cytokines may further contain linking regions also derived from corresponding linking regions in these factors. The hybrid cytokines offer a unique spectrum of activities useful in treating conditions for which the native cytokines are useful or in treating conditions characterized by an excess of the native cytokines.
Patent DE-69229615-T2 (DE)
Inventor: O'BRIEN MICHAEL R
IPC: G06Q20/38
Filed: 1992-05-06
Granted: 2000-02-10
Abstract: A system for automatically distributing discount coupons or certificates in a retail store, conditioned on a preselected combination of present and past shopping behavior of a customer whose order is being processed at a checkout stand. Generation of a printable discount coupon can be based on any desired combination of customer-supplied data, obtained from a customer identification data base, past shopping activity, derived from data gathered during previous customer visits to the store, and present shopping activity, as evidenced by items identified in the current customer order. If all of the preselected conditions for generation of a coupon are satisfied, the coupon is generated and printed at the checkout stand.
Patent DE-69306134-T2 (DE)
Inventor: TAKAHASHI TAKAO
IPC: B23P19/06
Filed: 1993-01-28
Granted: 1997-04-03
Abstract: A pierce nut (10) having a central pilot (15), a cylindrical flange portion (29) surrounding the pilot (15) and a groove (16) in the flange portion having at least one inclined side wall (22) and a bottom wall having a convex annular protuberance preferably comprising spaced arcuate protuberances (24a,24b,24c,24d) extending around the pilot (15) which deforms panel metal beneath the inclined side wall and providing anti-rotation means when the nut is attached to a metal panel. The outer groove side wall includes radial notches or grooves (30a,30b,30c,30d) which receive panel metal to provide anti-torque means. The improved die button (52) includes an annular lip (53) having an inside piercing edge (58) spaced from the end to pierce a smaller slug and an annular convex fillet (57) which deforms more panel metal into the nut groove to form a secure mechanical interlock between the nut and panel. <IMAGE>
Patent DE-69307725-T2 (DE)
Inventor: VAN OORD JAN
IPC: B65B69/00
Filed: 1993-11-09
Granted: 1997-05-15
Abstract: A device for processing foil-like material, such as opening and/or closing packing paper round an object (V), which device comprises a support (1) for the object in addition to a processing apparatus movable relative to the support, wherein the processing apparatus is provided with a carrier (5) movable over the foil material having at least a pair of wheels (9), whereof the rotation shaft of the wheels encloses an angle, this such that with this movement of the carrier the wheel peripheries exert a force on the foil material directed toward and/or away from each other in order to effect a closing or opening action on the foil material.
Patent DE-69308388-T2 (DE)
Inventor: BOMBARDELLI EZIO
IPC: C07D417/12
Filed: 1993-06-10
Granted: 1997-11-06
Abstract: Novel salts of non-steroidal anti-inflammatory substances and phosphatidic acids are provided. The novel salts are especially suitable for trans-dermal administration e.g. in the form of cutaneous patches, plasters or bandages.
Patent DE-69314452-T2 (DE)
Inventor: MELLO ARY O
IPC: B66B23/22
Filed: 1993-12-24
Granted: 1998-02-05
Abstract: The mount assembly (2) of an escalator balustrade incorporates brackets (4) secured to the escalator truss (6) which include a pocket (8) in which the lower edge of the glass balustrade panel (10) is located, secured by a wedge block (16) forcing a metal plate (14) against a paper or plastic gasket (12) mounted on the glass panel (10). Extruded plastic trim channels bolted to the brackets (4) locate the outer and inner deck panels (22,24). Continuous strips (30) of closed cell PVC/nitrile foam are sandwiched between the channels (18) and the balustrade (10) and extend the length of the balustrade. A one inch thick strip (32) of fibreglass nylon composite insulation strip is bonded to the underside of the inner deck panel (24) and is also continuous and uninterrupted for the length of the inner deck panel.
Patent DE-69317744-T2 (DE)
Inventor: PINAULT FRANCIS
IPC: H04B7/26
Filed: 1993-12-13
Granted: 1998-07-30
Abstract: The present invention relates to a device for searching for a connection between a terminal and a radio communications system. The device for searching for a connection between a terminal and a radio communications system comprises a synchronisation member for establishing, in response to a control signal, whether this connection can be made, and a timing member for producing the control signal, following an initial period, after a first waiting period, the timing member again producing the control signal after a second waiting period if it is established that the connection cannot be made following the first waiting period, the timing member moreover comprising means for fixing the duration of the second waiting period so that it is longer than that of the first waiting period. In the device which is arranged in a terminal provided with an energy storage system, the capacity of which is represented by a capacity indicator, the timing member comprises means for fixing at least one of these waiting periods as a function of the capacity indicator. <IMAGE>
Patent DE-69319632-T2 (DE)
Inventor: BOSLEY RODNEY W
IPC: A61L29/00
Filed: 1993-01-20
Granted: 1998-12-24
Abstract: Echogenic medical devices and methods of fabrication and of use are disclosed. The devices are adapted to be inserted into a patient. The device includes an elongated member (1502) including a material (1503) having an acoustic impedance different from that of the surrounding medium. The medium includes surrounding biological tissue or fluids surrounding the member (1502) when inserted into a passageway of the patient. The acoustic impedance of the elongated member (1502) is sufficiently different from the surrounding medium for enhancing an image produced in response to a sonic beam produced from imaging equipment. The elongated member (1502) also includes an interface layer (1506) of a high density metal (1510) of which the deposition on the base material (1503) of the member (1502) is ion beam assisted. The interface layer (1506) includes an outside surface (1507) having a plurality of particulate-type, discontinuous curved surfaces (1511,1708) of partially spherical indentations (1709) formed therein or spheres (1508) extending therefrom. The difference between the acoustic impedances of the interface layer (1506) and the surrounding medium along with the discontinuous surfaces (1511,1708) of the interface layer (1506) cooperate in response to a beam from sonic imaging equipment to significantly enhance the image of the medical device member. <IMAGE>
Patent DE-69323800-T2 (DE)
Inventor: SCHWAB KURT DR
IPC: G02B23/10
Filed: 1993-07-06
Granted: 1999-07-01
Abstract: A field glass (e.g. monocular, binoculars, aiming telescope) having means for alternatively observing additional information, an information carrier or an information deflecting means being disposed in the beam path, the information carrier or information deflecting means being disposed within the housing of the field glass and adapted to be brought into and out of the beam path between the objective and eyepiece. <IMAGE>
Patent DE-69326365-T2 (DE)
Inventor: VAN DER WAL JACOB CORNELIS
IPC: G06F13/00
Filed: 1993-02-10
Granted: 2000-02-03
Abstract: Method of transferring, via a transmission medium comprising asynchronously time-division-multiplexed transmission channels, a data stream composed of data cells. A monitoring apparatus at the beginning of the transmission medium stores, for each transmission channel, a counter position (variable) which, when a data cell arrives at said monitoring apparatus, is amended as a function of the time which has elapsed from a reference time instant. Depending on the amended counter position and a threshold value, the data cell is granted or refused access to the downstream transmission medium. In contrast to known methods, the reference time instant is determined by the monitoring apparatus completely, or at least partly, independently of the time instant of the appearance of the data cells. A first option provides for the monitoring apparatus to shift the reference time instant in time in accordance with a fixed sequence schedule. According to a second option, the reference time instant is shifted in time in accordance with a fixed time schedule. The method brings about a reduction in memory capacity. <IMAGE>
Patent DE-69331640-T2 (DE)
Inventor: ELLIS W
IPC: B41M5/24
Filed: 1993-11-17
Granted: 2002-09-05
Abstract: Unique laser ablation transfer ("LAT") imaging films presenting options of flexibility and versatility hitherto alien to this art are produced, on-demand, by toning appropriate substrate as to provide thereon an ablative discontinuous film topcoat comprising a contrast imaging amount of conventional or modified toner particulates.
Patent DE-69418896-T2 (DE)
Inventor: DUNBAR JAMES
IPC: A61K8/00
Filed: 1994-10-28
Granted: 2000-01-20
Abstract: The present invention encompasses a personal cleansing bar comprising from 10 parts to 70 parts by bar weight of sodium cocoyl isethionate (SCI), 4.5 parts to 50 parts magnesium soap and 4 parts to 15 parts liquid polyol, wherein said polyol has at least two alcohol groups attached to separate carbon atoms in the chain, and must be water soluble and liquid at room temperature. The bars of this invention are mild, lather better, and are easier to make than corresponding bars without liquid polyol.
Patent DE-69421943-T2 (DE)
Inventor: FAHLVIK ANNE KJERSTI
IPC: A61K49/04
Filed: 1994-09-27
Granted: 2000-05-18
Abstract: The invention relates to particulate contrast agents, especially contrast agents for MR imaging having a metal oxide core which is preferably superparamagnetic iron oxide. The particulate contrast agents are provided with a low coating density of a polyelectrolyte coating agent selected from structural polysaccharides and synthetic polymers, especially polyaminoacids. Unlike conventional coated particulates, the new particles have reduced or no effect on cardiovascular parameters, platelet depletion, complement activation and blood coagulation.
Patent DE-69427257-T2 (DE)
Inventor: JOUXTEL JEAN-CLAUDE
IPC: A23L17/00
Filed: 1994-09-21
Granted: 2002-03-14
Abstract: The present invention principally relates to a process for manufacturing a composite foodstuff and to a foodstuff obtained by the said process. The subject of the invention is a process comprising the steps consisting in:   - baking the pastry until golden brown during a prior cooking stage at a suitable temperature;   - placing the pastry and the stuffing in a package; - vacuum-packing and sealing the package containing the pastry and the stuffing; - cooking the foodstuff comprising the pastry and the stuffing in the package at a temperature which does not degrade the organoleptic properties of the stuffing.   The invention applies mainly to the fish and meat processing industries.
Patent DE-69430813-T2 (DE)
Inventor: PERSSON LARS
IPC: A61P29/00
Filed: 1994-11-18
Granted: 2003-01-30
Abstract: PCT No. PCT/SE94/01095 Sec. 371 Date Jul. 22, 1996 Sec. 102(e) Date Jul. 22, 1996 PCT Filed Nov. 18, 1994 PCT Pub. No. WO95/14477 PCT Pub. Date Jun. 1, 1995The present invention relates to the use of an ester of inositoltrisphosphate for the preparation of a medicament for preventing, alleviating or combatting inflammatory conditions in mammals including man. Injury or destruction of tissues should be understood as damage to an aggregation of specialized cells with a particular function both internally and externally in the body, such as different organs or parts of these, vessels, skin etc. Tissue damage involves a complex series of events such as dilatation of vessel walls e.g. arterioles, capillaries and venules, increased permeability of fluids including e.g. plasma proteins and increased blood flow. Increased vascular leakage often results in extravasation and oedema formation which characterize the damage of different tissues. Often tissue damage and inflammatory conditions are characterized by signs of pain, heat, redness, swelling and loss of function. Tissue damage is not defined as a disease per se but is often a component in different diseases of both acute or chronic nature.
Patent DE-69430978-T2 (DE)
Inventor: KWOK ROBERT J
IPC: C13B20/14
Filed: 1994-11-09
Granted: 2002-11-21
Abstract: The subject of the present invention is a process for the manufacture of crystalline sugar from an aqueous sugar juice (liquor) containing sugars and organic and inorganic impurities, including Ca<2+> and/or Mg<2+> ions, such as a sugar cane juice or a sugar beet juice, which comprises the operations:   (a) of concentrating the said sugar juice, in order to obtain a syrup, and (b) of crystallising the said syrup, in order to obtain a crystalline sugar and a molasses, characterised in that it additionally comprises an operation: (c) of tangential microfiltration, of tangential ultrafiltration or of tangential nanofiltration, this operation being carried out before the operation (a).   Another subject of the invention is a process for the manufacture of crystalline white sugar from a sugar juice of the sugar cane juice type, comprising the abovementioned process for the manufacture of crystalline sugar, completed by remelting, decolorisation and crystallisation operations. <IMAGE>
Patent DE-69501331-T2 (DE)
Inventor: CASTERS FRANCOIS
IPC: E04F21/24
Filed: 1995-04-11
Granted: 1998-07-23
Abstract: Machine for levelling concrete, of the type whereby poured concrete (2) is spread over a predetermined width and whereby this concrete (2) is skimmed off at a certain height, characterized in that the machine (1) itself can be adjusted in the width.